Mouth cancer debate worldwide

Feb. 10, 2011
Dental hygienists from around the world meet to discuss mouth cancer, a disease that still affects some one in 10 people per 100,000 globally.

The second North American/Global Dental Hygiene Research Conference will be held Oct. 20-22, 2011, in Maryland.

To read more about mouth cancer, go to mouth cancer.

At the conference, dental hygienists will share their research, and invited speakers will present new research related to oral cancer, smoking cessation interventions, bisphosphonate-induced osteonecrosis, and remineralisation therapies.

Ann Spolarich, associate director of the National Center for Dental Hygiene Research & Practice, lent her support to finding a cure for the disease.

"During one of the plenary sessions at the conference, a leading international expert will explore the state of the science regarding oral cancer risk assessment, diagnosis and management, including a discussion about the reliability and validity of available in-office oral cancer screening tests," Spolarich said.

"Further, results from a major practice-based research study that examines how dental hygienists can best provide tobacco cessation counselling will be presented. It is also quite likely that original research papers submitted for oral and poster presentations will address oral cancer and tobacco use as well."

Dr Nigel Carter, chief executive of the International Dental Health Foundation, expressed delight at oral cancer appearing on the agenda.

"Through Mouth Cancer Action Month we have campaigned in the UK for greater awareness of oral cancer for several years," Dr. Carter said. "The worldwide challenge is equally daunting and the conference will provide an excellent opportunity to increase awareness of the disease and hopefully stimulate debate on new approaches to prevention, diagnosis and treatment."

For a registration form, an abstract submission form (due March 15, 2011) and further information, contact Jane L Forrest, RDH, EdD, director at [email protected] or Spolarich, RDH PhD, associate director at [email protected].

For more information, go to

To comment on this topic, go to